Each vial contains: Active ingredient: 3.5 mg of bortezomib as a sterile lyophilized powder.
After reconstitution with 1.4 ml: 1 ml of solution for subcutaneous injection contains 2.5 mg bortezomib.
After reconstitution with 3.5 ml: 1 ml of solution for intravenous injection contains 1 mg bortezomib.
The reconstituted solution is clear and colourless, with a final pH of 4 to 7.
The compatible reconstitution and infusion solution for intravenous and subcutaneous use is 0.9% Sodium Chloride.
Excipients/Inactive Ingredients: Mannitol.